Product
89Zr-MMOT0530A
1 clinical trial
7 indications
Indication
Ovarian CancerIndication
Ovarian DiseasesIndication
Adnexal DiseasesIndication
Pancreatic CancerIndication
Digestive System NeoplasmsIndication
Gastrointestinal DiseasesIndication
Pancreatic DiseasesClinical trial
89Zr-MMOT0530A PET Imaging in Patients With Unresectable Pancreatic or Platinum-resistant Ovarian Cancer Before Treatment With DMOT4039A. A Separate Study to the Phase I Study Protocol DMO4993gStatus: Completed, Estimated PCD: 2014-05-01